View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
October 9, 2012

New £24m pharmaceutical research centre set for Birmingham, UK

A £24m clinical research centre is to be built in Birmingham, UK, to bring pharmaceutical professionals together in order to advance development of research findings.

By Heidi Vella

University of Birmingham

A £24m clinical research centre is to be built in Birmingham, UK, to bring pharmaceutical professionals together in order to advance development of research findings.

The new Institute for Translational Medicine will receive £12m from the UK Government’s ‘city deal’, with the University of Birmingham and University Hospitals Birmingham contributing the remaining the funds.

The aim of the centre is to progress major research findings from the University of Birmingham into treatment drugs for illnesses such as cancer and liver disease.

It is also hoped the new clinic will make it easier for SMEs and large pharmaceutical and biotech companies to collaborate closer.

In addition, it will increase capacity for clinical trials and make it simpler for patients to be see clinicians and researchers in the same facility.

“This investment will further enhance our expertise in clinical trials and ensure that the University of Birmingham’s world-class medical research translates directly to enhanced treatments for patients."

Provost and vice-principal of University of Birmingham, professor Michael Sheppard, said: "This investment will further enhance our expertise in clinical trials and ensure that the University of Birmingham’s world-class medical research translates directly to enhanced treatments for patients.

"Our outstanding track record in translational medicine makes Birmingham the ideal place to locate the institute."

Investment in a clinical trial goes against the current trend of pharmaceutical companies slashing redevelopment and development budgets.

Recently Sanofi cut research and development jobs by around 2,000 and in the last year Pfizer announced significant cuts to its budget and closed down a prominent research site in Sandwich, UK.


Image: University of Birmingham Medical School. Photo: courtesy of Gavin Warrins.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology